Theophylline (Anhydrous)
NDC 69367-415, Theophylline Anhydrous, tablet, extended release, from Westminster Pharmaceuticals, LLC.
- Product NDC
- 69367-415
- Status
- Listed
- Labeler
- Westminster Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040560
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69367-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- THEOPHYLLINE ANHYDROUS600 mg/1
Pharmacologic classes
Methylxanthine [EPC]; Xanthines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69367-415-01 | 69367041501 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-415-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/04f1d1da-ce61-45b3-acf4-903cc81d16daNADAC price for package 69367041501
GET /v1/drugs/nadac/69367041501
Use it
Look up 69367-415 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69367-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69367-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.